AU2002364750A1 - Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans - Google Patents

Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans

Info

Publication number
AU2002364750A1
AU2002364750A1 AU2002364750A AU2002364750A AU2002364750A1 AU 2002364750 A1 AU2002364750 A1 AU 2002364750A1 AU 2002364750 A AU2002364750 A AU 2002364750A AU 2002364750 A AU2002364750 A AU 2002364750A AU 2002364750 A1 AU2002364750 A1 AU 2002364750A1
Authority
AU
Australia
Prior art keywords
mammals
humans
use
small intestine
digestive enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364750A
Other versions
AU2002364750A8 (en
Inventor
Peter-Colin Gregory
Daniela Heldt
Josef Kamphues
Christian Mandischer
Robert Tabeling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Abbott Products GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US33943801P priority Critical
Priority to US60/339,438 priority
Application filed by Abbott Products GmbH filed Critical Abbott Products GmbH
Priority to PCT/EP2002/014148 priority patent/WO2003051345A2/en
Publication of AU2002364750A1 publication Critical patent/AU2002364750A1/en
Publication of AU2002364750A8 publication Critical patent/AU2002364750A8/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
AU2002364750A 2001-12-14 2002-12-12 Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans Abandoned AU2002364750A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US33943801P true 2001-12-14 2001-12-14
US60/339,438 2001-12-14
PCT/EP2002/014148 WO2003051345A2 (en) 2001-12-14 2002-12-12 Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans

Publications (2)

Publication Number Publication Date
AU2002364750A1 true AU2002364750A1 (en) 2003-06-30
AU2002364750A8 AU2002364750A8 (en) 2003-06-30

Family

ID=23329006

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364750A Abandoned AU2002364750A1 (en) 2001-12-14 2002-12-12 Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans

Country Status (2)

Country Link
AU (1) AU2002364750A1 (en)
WO (1) WO2003051345A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP2373693A4 (en) * 2009-01-06 2012-04-25 Curelon Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
ES2668909T3 (en) 2009-01-06 2018-05-23 Galenagen, Llc Compositions comprising protease, amylase and lipase for use in the treatment of Staphylococcus aureus infections
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
SE535296C2 (en) 2010-09-08 2012-06-19 Anara Ab Maturation of the digestive tract
GB2503852B (en) 2011-04-21 2018-12-12 Curemark Llc Compounds for the treatment of neuropsychiatric disorders
AU2013206890B2 (en) * 2012-01-03 2017-09-28 Curemark, Llc Methods of treating behavioral symptoms of neurological and mental disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2638088C3 (en) * 1976-08-24 1979-06-21 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
DE4332985A1 (en) * 1993-09-28 1995-03-30 Konrad Peter Maria Dr Sommer Pharmaceutical composition for the treatment of exocrine pancreas dysfunction
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof

Also Published As

Publication number Publication date
WO2003051345A2 (en) 2003-06-26
WO2003051345A3 (en) 2003-07-31
AU2002364750A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
AU733544C (en) Treatment and diagnosis of cancer
AU780278C (en) System and method of treating abnormal tissue in the human esophagus
AP1635A (en) Azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease
AU780422C (en) Human desaturase gene and uses thereof
AU2002243495A1 (en) Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
AUPR638101A0 (en) Composition and method for treatment of disease
HK1044020A1 (en) Compounds and methods for treatment and diagnosis of chlamydialinfection
AU5788300A (en) Medical treatment method and kit
AU2002320185A1 (en) Biological activity of ak155
AU2146495A (en) Enzyme treatment of glucans
EP1408820A4 (en) Capsule and method for treating or diagnosing the intestinal tract
AU5910998A (en) Compounds and their combinations for the treatment of influenza infection
AU2002303626A1 (en) Composition and methods for treatment of hyperplasia
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2002351505A1 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU2002318364A1 (en) Novel human histone deacetylases
ZA200404849B (en) Compositions and methods for the diagnosis and treatment of tumor
IL138664D0 (en) Smilagenin and anzurogenin-d for the treatment of alheimer's disease
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
AU2003900747A0 (en) Diagnosis and treatment of pancreatic cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2560599A (en) Diagnosis and treatment of aur1 and/or aur2 related disorders
PT1626058E (en) Compositions and methods for the diagnosis of tumour
AU2002352726A1 (en) Formulations and methods for treatment or amelioration of inflammatory conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase